Chemoinformaics analysis of Zizyberenalic acid
| Molecular Weight | 597.801 | nRot | 10 |
| Heavy Atom Molecular Weight | 546.393 | nRig | 25 |
| Exact Molecular Weight | 597.389 | nRing | 4 |
| Solubility: LogS | -4.444 | nHRing | 3 |
| Solubility: LogP | 4.46 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 94 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 51 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 5 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 98.6264 |
| nHD | 3 | BPOL | 61.5016 |
| QED | 0.427 |
| Synth | 5.975 |
| Natural Product Likeliness | 0.925 |
| NR-PPAR-gamma | 0.286 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.141 |
| HIA | 0.005 |
| CACO-2 | -5.325 |
| MDCK | 0.0000135 |
| BBB | 0.222 |
| PPB | 0.876206 |
| VDSS | 1.244 |
| FU | 0.0317267 |
| CYP1A2-inh | 0.02 |
| CYP1A2-sub | 0.074 |
| CYP2c19-inh | 0.736 |
| CYP2c19-sub | 0.879 |
| CYP2c9-inh | 0.883 |
| CYP2c9-sub | 0.18 |
| CYP2d6-inh | 0.045 |
| CYP2d6-sub | 0.692 |
| CYP3a4-inh | 0.954 |
| CYP3a4-sub | 0.759 |
| CL | 9.027 |
| T12 | 0.305 |
| hERG | 0.462 |
| Ames | 0.056 |
| ROA | 0.461 |
| SkinSen | 0.102 |
| Carcinogencity | 0.626 |
| EI | 0.007 |
| Respiratory | 0.67 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.628676 |